Basal-like breast cancer: A review

被引：4
作者：
Treilleux, Isabelle [1 ]
Morellon-Mialhe, Blandine [1 ]
机构：
[1] Ctr Leon Berard, Serv Anat Pathol, F-69373 Lyon 08, France
来源：
ANNALES DE PATHOLOGIE | 2009年 / 29卷 / 03期
关键词：
Breast cancer; Basal phenotype; Basal cytokeratins; Myoepithelial markers; Immunohistochemistry; Prognosis; IN-SITU HYBRIDIZATION; DUCTAL CARCINOMA; EPITHELIAL PHENOTYPE; EXPRESSION; SUBTYPE; AMPLIFICATION; MUTATIONS; RECEPTOR; MARKERS; EGFR;
D O I：
10.1016/j.annpat.2009.04.001
中图分类号：
R36 [病理学];
学科分类号：
100104 ;
摘要：
Breast cancers of basal phenotype have been identified by molecular profiting and are associated with a poor prognosis. This review describes the morphological characteristics of these tumors and focuses on their profiting using immunohistochemistry: absence of detectable hormone receptors and HER2, expression of basal cytokeratins (CK5/6, CK14), myoepithelial markers (p63, smooth muscle actin) and HER1. This phenotype may be encountered in all histological types of breast cancer and is further divided into three subtypes according to prognosis and protein profiting. Pure basal and basal/myoepithelial subtypes have a poor prognosis in contrast to the myoepithelial subtype. (C) 2009 Elsevier Masson SAS. All rights reserved.
引用
收藏
页码：180 / 186
页数：7
相关论文
共 38 条
  • [1] Basal-like breast carcinomas: clinical outcome and response to chemotherapy
    Banerjee, S.
    Reis-Filho, J. S.
    Ashley, S.
    Steele, D.
    Ashworth, A.
    Lakhani, S. R.
    Smith, I. E.
    [J]. JOURNAL OF CLINICAL PATHOLOGY, 2006, 59 (07) : 729 - 735
  • [2] Gene expression profiling shows medullary breast cancer is a subgroup of basal breast cancers
    Bertucci, Francois
    Finetti, Pascal
    Cervera, Nathalie
    Charafe-Jauffret, Emmanuelle
    Mamessier, Emilie
    Adelaide, Jose
    Debono, Stephane
    Houvenaeghel, Gilles
    Maraninchi, Dominique
    Viens, Patrice
    Charpin, Colette
    Jacquemier, Jocelyne
    Birnbaum, Daniel
    [J]. CANCER RESEARCH, 2006, 66 (09) : 4636 - 4644
  • [3] Birnbaum D, 2004, INT J ONCOL, V25, P249
  • [4] Basal-like breast cancer defined by five biomarkers has superior prognostic value then triple-negative phenotype
    Cheang, Maggie C. U.
    Voduc, David
    Bajdik, Chris
    Leung, Samuel
    McKinney, Steven
    Chia, Stephen K.
    Perou, Charles M.
    Nielsen, Torsten O.
    [J]. CLINICAL CANCER RESEARCH, 2008, 14 (05) : 1368 - 1376
  • [5] Keratin expression in human tissues and neoplasms
    Chu, PG
    Weiss, LM
    [J]. HISTOPATHOLOGY, 2002, 40 (05) : 403 - 439
  • [6] A basal epithelial phenotype is more frequent in interval breast cancers compared with screen detected tumors
    Collett, K
    Stefansson, IM
    Eide, J
    Braaten, A
    Wang, H
    Eide, GE
    Thoresen, SO
    Foulkes, WD
    Akslen, LA
    [J]. CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION, 2005, 14 (05) : 1108 - 1112
  • [7] Basal phenotype of ductal carcinoma in situ:: recognition and immunohistologic profile
    Dabbs, David J.
    Chivukula, Mamatha
    Carter, Gloria
    Bhargava, Rohit
    [J]. MODERN PATHOLOGY, 2006, 19 (11) : 1506 - 1511
  • [8] Clinical and pathologic aspects of basal-like breast cancers
    Fadare, Oluwole
    Tavassoli, Fattaneh A.
    [J]. NATURE CLINICAL PRACTICE ONCOLOGY, 2008, 5 (03): : 149 - 159
  • [9] The expression of cytokeratin 5/6 in invasive lobular carcinoma of the breast: evidence of a basal-like subset?
    Fadare, Oluwole
    Wang, Sa A.
    Hileeto, Denise
    [J]. HUMAN PATHOLOGY, 2008, 39 (03) : 331 - 336
  • [10] The phenotypic spectrum of basal-like breast cancers: a critical appraisal
    Fadare, Oluwole
    Tavassoli, Fattaneh A.
    [J]. ADVANCES IN ANATOMIC PATHOLOGY, 2007, 14 (05) : 358 - 373
1234